The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
The Dale E. McFarlin memorial lecture: The immunology of the multiple sclerosis lesion
Abstract
This review surveys the structural terrain of the multiple sclerosis (MS) lesion from the standpoint of its immunologic responsiveness. Similarities in lymphocyte trafficking patterns are noted between MS and its laboratory model, experimental allergic encephalomyelitis (EAE), and in both conditions, the inflammatory response is selective for the central nervous system (CNS). While adhesion molecules abound during the genesis of the MS lesion, none has yet been found that is unusual to this condition and, indeed, many occur in other neurodegenerative states in which inflammation is not a component of the lesion. Cytokines are effective regulators of lymphocyte traffic and adhesion events and most can be located in MS lesions. Of these, tumor necrosis factor-alpha (TNF-alpha) occurs in abundance. Together with its known affinity to effect myelin and oligodendrocyte destruction and to up-regulate adhesion molecule expression, the presence of TNF-alpha renders it an important player in lesion pathogenesis. Demyelination is described as a rapid lytic event, perhaps involving cytokines and immunoglobulin, and structural similarities are common in the patterns seen in MS and EAE. Oligodendrocytes survive the initial stages of lesion formation. Moreover, they are now known to proliferate and elaborate new myelin at the same time as myelin is being degraded. This paradoxical reparatory scenario is apparently a transient event although rims of remyelination persist about the margins of chronic lesions. The speculation is reiterated that the demise of the oligodendrocyte in MS may occur late in lesion formation and may be in part related to the expression of heat shock proteins (specifically, members of the hsp 60 family), potent stimulators of T-cell receptor-gamma delta T cells that have been claimed to have cytolytic activity and that have been located in chronic active MS lesions. In sum, while no single immune system molecule can be assigned as unusual to the CNS in MS, and while there appears to be nothing unique about the manner in which the CNS responds to the inflammation, the true uniqueness of the situation in MS is probably related to the many, normally sequestered, specific antigens within the myelin sheath and the biology of the myelinating cell, the oligodendrocyte.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Raff, M. C., Miller, R. H., & Noble, M. (1983) · Nature · doi:10.1038/303390a0 · Cited by 2,030
Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro
Selmaj, K. W., & Raine, C. S. (1988) · Annals of Neurology · doi:10.1002/ana.410230405 · Cited by 1,368
Self-citationCell death and control of cell survival in the oligodendrocyte lineage
Barres, B. A., Hart, I. K., Coles, H. S. R., Burne, J. F., Voyvodic, J. T., Richardson, W. D., & Raff, M. C. (1992) · Cell · doi:10.1016/0092-8674(92)90531-g · Cited by 1,345
Tumor necrosis factor identified in multiple sclerosis brain.
Hofman, F. M., Hinton, D. R., Johnson, K., & Merrill, J. E. (1989) · The Journal of experimental medicine · doi:10.1084/jem.170.2.607 · Cited by 801
Ruddle, N. H., Bergman, C. M., McGrath, K. M., Lingenheld, E. G., Grunnet, M. L., Padula, S. J., & Clark, R. B. (1990) · The Journal of experimental medicine · doi:10.1084/jem.172.4.1193 · Cited by 688
Multiple sclerosis: Remyelination of nascent lesions: Remyelination of nascent lesions
Prineas, J. W., Barnard, R. O., Kwon, E. E., Sharer, L. R., & Cho, E. ‐. (1993) · Annals of Neurology · doi:10.1002/ana.410330203 · Cited by 574
O'Brien, R. L., Happ, M. P., Dallas, A., Palmer, E., Kubo, R., & Born, W. K. (1989) · Cell · doi:10.1016/0092-8674(89)90135-9 · Cited by 482
Remyelination in multiple sclerosis
Prineas, J. W., & Connell, F. (1979) · Annals of Neurology · doi:10.1002/ana.410050105 · Cited by 454
Cytokine cytotoxicity against oligodendrocytes. Apoptosis induced by lymphotoxin
Selmaj, K., Raine, C. S., Farooq, M., Norton, W. T., & Brosnan, C. F. (1991) · The Journal of Immunology · doi:10.4049/jimmunol.147.5.1522 · Cited by 451
Self-citationRemyelination in multiple sclerosis
Piaton, G., Williams, A., Seilhean, D., & Lubetzki, C. (2009) · Progress in Brain Research · doi:10.1016/s0079-6123(09)17530-1 · Cited by 441
Anti—tumor necrosis factor therapy abrogates autoimmune demyelination
Selmaj, K., Raine, C. S., & Cross, A. H. (1991) · Annals of Neurology · doi:10.1002/ana.410300510 · Cited by 436
Self-citationBiology of disease. Analysis of autoimmune demyelination: its impact upon multiple sclerosis.
Raine, C. S. (1984) · PubMed · Cited by 424
Self-citationOksenberg, J. R., Panzara, M. A., Begovich, A. B., Mitchell, D., Erlich, H. A., Murray, R. S., Shimonkevitz, R., Sherritt, M., Rothbard, J., Bernard, C. C. A., et al. (1993) · Nature · doi:10.1038/362068a0 · Cited by 394
Sobel, R. A., Mitchell, M. E., & Fondren, G. (1990) · Europe PMC (PubMed Central) · Cited by 388
Katz, D., Taubenberger, J. K., Cannella, B., McFarlin, D. E., Raine, C. S., & McFarland, H. F. (1993) · Annals of Neurology · doi:10.1002/ana.410340507 · Cited by 387
Self-citationShared Human T Cell Receptor V β Usage to Immunodominant Regions of Myelin Basic Protein
Wucherpfennig, K. W., Ota, K., Endo, N., Seidman, J. G., Rosenzweig, A., Weiner, H. L., & Hafler, D. A. (1990) · Science · doi:10.1126/science.1693015 · Cited by 386
Racke, M. K., Dhib-Jalbut, S., Cannella, B., Albert, P. S., Raine, C. S., & McFarlin, D. E. (1991) · The Journal of Immunology · doi:10.4049/jimmunol.146.9.3012 · Cited by 378
Self-citationHickey, W. F. (1991) · Brain Pathology · doi:10.1111/j.1750-3639.1991.tb00646.x · Cited by 357
Immunoregulatory molecules and IL 2 receptors identified in multiple sclerosis brain.
Hofman, F. M., Von Hanwehr, R. I., Dinarello, C. A., Mizel, S. B., Hinton, D., & Merrill, J. E. (1986) · The Journal of Immunology · doi:10.4049/jimmunol.136.9.3239 · Cited by 317
Multiple Sclerosis: Remyelination in Acute Lesions
Raine, C. S., & WU, E. (1993) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199305000-00003 · Cited by 285
Self-citationSelmaj, K., Brosnan, C. F., & Raine, C. S. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.15.6452 · Cited by 283
Self-citationGamma delta T-cell receptor repertoire in acute multiple sclerosis lesions.
Wucherpfennig, K. W., Newcombe, J., Li, H., Keddy, C., Cuzner, M. L., & Hafler, D. A. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.10.4588 · Cited by 278
Multiple sclerosis. Oligodendrocyte proliferation and differentiation in fresh lesions.
Prineas, J. W., Kwon, E. E., Goldenberg, P. Z., Ilyas, A. A., Quarles, R. H., Benjamins, J. A., & Sprinkle, T. J. (1989) · PubMed · Cited by 265
Multiple sclerosis. Oligodendrocyte survival and proliferation in an active established lesion.
Raine, C. S., Scheinberg, L. C., & Waltz, J. M. (1981) · PubMed · Cited by 264
Self-citationRaine, C. S., Cannella, B., Duijvestijn, A. M., & Cross, A. H. (1990) · PubMed · Cited by 229
Self-citationThe fine structure of chronically active multiple sclerosis plaques
Prineas, J. W., & Connell, F. (1978) · Neurology · doi:10.1212/wnl.28.9_part_2.68 · Cited by 190
Cannella, B., Cross, A. H., & Raine, C. S. (1990) · The Journal of experimental medicine · doi:10.1084/jem.172.5.1521 · Cited by 170
Self-citationChronologic neuropathology of relapsing experimental allergic encephalomyelitis in the mouse.
Brown, A., McFarlin, D. E., & Raine, C. S. (1982) · PubMed · Cited by 166
Self-citationLee, S. C., Moore, G. R. W., Golenwsky, G., & Raine, C. S. (1990) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199003000-00005 · Cited by 149
Self-citationMultiple sclerosis: a pivotal role for the T cell in lesion development
Raine, C. S. (1991) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.1991.tb00724.x · Cited by 124
Self-citationElectron microscopy and immunoperoxidase studies of early multiple sclerosis lesions
Prineas, J. W., & Raine, C. S. (1976) · Neurology · doi:10.1212/wnl.26.6_part_2.29 · Cited by 112
Self-citationOn the immunopathology of plaque development and repair in multiple sclerosis
Raine, C. S., & Scheinberg, L. C. (1988) · Journal of Neuroimmunology · doi:10.1016/0165-5728(88)90160-9 · Cited by 106
Self-citationOkazaki, M. D. H. (1991) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(12)60677-6 · Cited by 88
Raine, C. S., Mokhtarian, F., & McFarlin, D. E. (1984) · PubMed · Cited by 85
Self-citationAttachment of myelin to coated pits on macrophages in experimental allergic encephalomyelitis
Epstein, L. G., Prineas, J. W., & Raine, C. S. (1983) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(83)90167-3 · Cited by 83
Self-citationCross, A. H., O'Mara, T., & Raine, C. S. (1993) · Neurology · doi:10.1212/wnl.43.5.1028 · Cited by 78
Self-citationRemyelination in the Human Central Nervous System
Ghatak, N. R., Leshner, R. T., Price, A. C., & Felton, W. L. (1989) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-198909000-00002 · Cited by 78
Selmaj, K. W., Brosnan, C. F., & Raine, C. S. (1992) · Neurology · doi:10.1212/wnl.42.4.795 · Cited by 77
Self-citationWu, E., & Raine, C. S. (1992) · PubMed · Cited by 75
Self-citationInteraction of astrocytes and newly formed oligodendrocytes in resolving multiple sclerosis lesions.
Prineas, J. W., Kwon, E. E., Goldenberg, P. Z., Cho, E. S., & Sharer, L. R. (1990) · PubMed · Cited by 65
Interaction of T Lymphocytes with Cerebral Endothelial Cells in vitro
Wekerle, H., Engelhardt, B., Risau, W., & Meyermann, R. (1991) · Brain Pathology · doi:10.1111/j.1750-3639.1991.tb00647.x · Cited by 48
Relapsing autoimmune demyelination: a role for vascular addressins
Cannella, B., Cross, A. H., & Raine, C. S. (1991) · Journal of Neuroimmunology · doi:10.1016/0165-5728(91)90183-8 · Cited by 38
Self-citationAdhesion molecules and central nervous system inflammation
Raine, C. S., & Cannella, B. (1992) · Seminars in Neuroscience · doi:10.1016/1044-5765(92)90003-k · Cited by 36
Self-citationThe role of cytokines in inflammatory conditions of the central nervous system
Selmaj, K. W. (1992) · Seminars in Neuroscience · doi:10.1016/1044-5765(92)90005-m · Cited by 35
Immunogold localization and analysis of IgG during immune-mediated demyelination.
Gr, M., & Raine, C. S. (1988) · PubMed · Cited by 34
Self-citationWu, E., Brosnan, C. F., & Raine, C. S. (1993) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199303000-00005 · Cited by 31
Self-citation
Cited by
Multiple Sclerosis — The Plaque and Its Pathogenesis
Frohman, E. M., Racke, M. K., & Raine, C. S. (2006) · New England Journal of Medicine · doi:10.1056/nejmra052130 · Cited by 1,740
Self-citationBlood‐brain barrier‐specific properties of a human adult brain endothelial cell line
Weksler, B. B., Subileau, E. A., Perrière, N., Charneau, P., Holloway, K., Leveque, M., Tricoire‐Leignel, H., Nicotra, A., Bourdoulous, S., Turowski, P., et al. (2005) · The FASEB Journal · doi:10.1096/fj.04-3458fje · Cited by 1,330
Relapsing and remitting multiple sclerosis: Pathology of the newly forming lesion
Barnett, M. H., & Prineas, J. W. (2004) · Annals of Neurology · doi:10.1002/ana.20016 · Cited by 1,185
Distinct Patterns of Multiple Sclerosis Pathology Indicates Heterogeneity in Pathogenesis
Lucchinetti, C. F., Brück, W., Rodriguez, M., & Lassmann, H. (1996) · Brain Pathology · doi:10.1111/j.1750-3639.1996.tb00854.x · Cited by 733
TNF is a potent anti-inflammatory cytokine in autoimmune-mediated demyelination
Liu, J., Marino, M. W., Wong, G., Grail, D., Dunn, A., Bettadapura, J., Slavin, A. J., Old, L., & Bernard, C. C. A. (1998) · Nature Medicine · doi:10.1038/nm0198-078 · Cited by 550
Metadata
- Authors
- Raine, C. S.
- Venue
- Annals of Neurology
- Publisher
- Wiley
- Published
- 1994
- Volume
- 36
- Issue
- S1
- Pages
- S61-S72
- ISSN
- 0364-5134 (ISSN-L)
- 1531-8249
- OpenAlex
- W2153734830
- Cited by
- 285
- References
- 46
- FWCI
- 16.40
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.